Public Procurement Organizations (PPO) are rethinking existing practices as currently, quality of care is compromised and they do not lead to economic most advantageous purchasing. PPO involved in different PPI/PCP are teaming up around a novel approach of Value Based Procurement (VBP) joined by national/regional procurement organizations and service providers with a common vision, a value based procurement of innovative solutions to enable the needed transformation of health and social care delivery. The EURIPHI consortium involves 14 PPO, 10 with a regional or national remit and service providers from 6 countries who together, procure for more than 200 care service providers. The European Health Public Procurement Alliance members are also contributing to the project. This provides a strong basis to build out a Value Based PPI Community of Practice (CoP) to successfully achieve one of the key objectives of the CSA. The EURIPHI common vision is to build out around a MEAT VBP framework which will be made accessible with adaptions necessary to support the cross-border PPI leading to “MEAT Value Based PPI”. Cross-border PPI-Legal guidance will be developed by legal expert partners. Innovative solutions will be identified in the fields of rapid diagnostic (RD) tools in infectious disease and in the most promising integrated care services (IC). The identification of specific demands and prioritization will be done by expert partners and through the establishment of the Health Regional Network including stakeholders. Following an open market consultation, case testing will be performed for 1-2 RD and 3-4 IC innovative solutions and serve as an input for the PPI or PCP writing of SC1-BHC-20-2020. Dissemination and exploitation will be done by partners with a European or International remit and by an involvement of all partners in a blog series and EURIPHI Insights, with the support of a permanent secretariat.

Public procurers in ProEmpower aim to procure a disease self-management solution to help meet the imminent threat of a diabetes epidemic. ProEmpower will make person-centred care reality - giving the patient the steering wheel - for optimal health outcomes. Very significant synergies will be reaped by supporting all 10 action areas of diabetes management in an integrated ICT solution. Early detection, personal decision support, self management and peer support are to be delivered from a platform with full interoperable and secure access to the necessary devices and health records. ProEmpower will apply the internationally acclaimed Chronic Care Model to specify support needs for type 2 diabetes at all stages. Self-management and treatment will be supported by personalised guidelines and making the best use of clinical data. In this way a quality culture in healthcare will be fostered and learning healthcare systems made reality. Suppliers will be rigorously evaluated after each of the four procurement phases, comprising (I) an open market consultation supported by the European eHealth Competition, (II) specification of architecture and system aligned to requirements of patients, peers and providers, (III) prototype development and testing with end-users and (IV) effectiveness proven in a trial with 200 patients and 40 professionals. Fully rolled out in the four countries, enabled by procurers with the authority and capacity in their countries and regions, ProEmpower will serve 12 million diabetes patients. Reductions in diabetes-related death, amputation, blindness and renal failure promise cost relief of € 53 billion over 7 years in the four countries. Suppliers can expect a turnover of € 5 billion a year. Proven ability to cover the four different health systems promises ProEmpower suppliers easy entry into other EU markets and beyond, a very strong contribution to overcoming fragmentation of demand and fostering the global market.